Brook.ai Appoints Former Teladoc COO and Healthcare Veteran Mike Waters as Chairman of the Board
SEATTLE, Oct. 21, 2025 /PRNewswire/ — Brook.ai, the company making remote care an integral part of U.S. healthcare by extending continuity of care outside... Read more.
U Power Signs Initial €540,000 Sales Agreement with Polestar Energy for the Purchase and Deployment of Twenty Battery-Swapping Electric Vans in Southern Europe
U Power Expects Additional Orders for Up to 2,000 Electric Vans and Compatible Battery-Swapping Stations In the Future SHANGHAI, Oct. 21, 2025 /PRNewswire/ —... Read more.
Trinity Capital Inc. Provides $15 Million in Growth Capital to Kard, Accelerating Growth of Its Commerce Media Network
PHOENIX, Oct. 21, 2025 /PRNewswire/ — Trinity Capital Inc. (Nasdaq: TRIN) (the “Company”), a leading alternative asset manager, today announced... Read more.
Trust & Will® Names Jackie Frommer Chief Commercial Officer to Drive Enterprise Growth and Financial Services Expansion
SAN DIEGO, Oct. 21, 2025 /PRNewswire/ — Trust & Will, the leader in online estate planning, today announced the appointment of Jackie Frommer as Chief... Read more.
Spectral Capital Corporation Reports $26.1 Million in 2024 Audited Revenue for 42 Telecom Ltd.
Newly acquired subsidiary achieves 38% revenue growth and returns to profitability in FY 2024 SEATTLE, Oct. 21, 2025 /PRNewswire/ — Spectral Capital Corporation... Read more.
Galaxy Announces Third Quarter 2025 Financial Results
NEW YORK, Oct. 21, 2025 /PRNewswire/ – Galaxy Digital Inc. (Nasdaq: GLXY) (TSX: GLXY) (the “Company” or “GDI”) today released financial... Read more.
Jacobs to Hold Its Fiscal Fourth Quarter and Full Year 2025 Earnings Conference Call and Webcast
DALLAS, Oct. 21, 2025 /PRNewswire/ — Jacobs (NYSE: J) plans to release its fiscal fourth quarter and full year 2025 earnings results before market open on... Read more.
DrugBank Announces Leadership Transition as Company Accelerates into AI-Driven Future
EDMONTON, AB, Oct. 21, 2025 /PRNewswire/ – DrugBank, the premier provider of structured biomedical intelligence, today announced a strategic leadership transition... Read more.
Change in the Sobi Board of Directors
STOCKHOLM, Oct. 21, 2025 /PRNewswire/ — Sobi® (STO: SOBI), a global biopharmaceutical company today announced that Helena Saxon a member of the Sobi board... Read more.
PleoPharma, Inc. Closes $36 Million Series B Financing Round
Financing led by Biotech Specialist Funds and a Generalist with significant participation from Series A investors Proceeds will support the Phase 3 Program for... Read more.